Multiple sclerosis: Disease biomarkers as indicated by pathophysiology (Englisch)
- Neue Suche nach: Berger, T.
- Neue Suche nach: Reindl, M.
- Neue Suche nach: Berger, T.
- Neue Suche nach: Reindl, M.
In:
JOURNAL OF THE NEUROLOGICAL SCIENCES
;
259
, 1-2
;
21-26
;
2007
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
-
Beteiligte:Berger, T. ( Autor:in ) / Reindl, M. ( Autor:in )
-
Erschienen in:JOURNAL OF THE NEUROLOGICAL SCIENCES ; 259, 1-2 ; 21-26
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2007
-
Format / Umfang:6 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 259, Ausgabe 1-2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
IntroductionHommes, O. R. et al. | 2007
- 2
-
The Board of the European Charcot Foundation thanks the Editorial Experts who contributed to this issue by reviewing the manuscripts| 2007
- 3
-
Multiple sclerosis: Is there neurodegeneration independent from inflammation?Lassmann, H. et al. | 2007
- 7
-
Inflammatory demyelination and neurodegeneration in early multiple sclerosisCharil, A. / Filippi, M. et al. | 2007
- 16
-
Cerebral blood perfusion changes in multiple sclerosisWuerfel, J. / Paul, F. / Zipp, F. et al. | 2007
- 21
-
Multiple sclerosis: Disease biomarkers as indicated by pathophysiologyBerger, T. / Reindl, M. et al. | 2007
- 27
-
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosisNeuhaus, O. / Kieseier, B. C. / Hartung, H. P. et al. | 2007
- 38
-
Approved drugs and their problems in patient care: Routes of administration and dosingCook, S. D. et al. | 2007
- 42
-
MS treatment: Postmarketing studiesMontalban, X. et al. | 2007
- 46
-
Inflammation versus neurodegeneration: Consequences for treatmentPalace, J. et al. | 2007
- 50
-
“Thinking without thinking? about natalizumab and PMLRansohoff, R. M. et al. | 2007
- 53
-
Death receptor expression and function at the human blood brain barrierWosik, K. / Biernacki, K. / Khouzam, M. P. / Prat, A. et al. | 2007
- 61
-
Intravenous immunoglobulin in MS: Promise or failure?Fazekas, F. / Strasser-Fuchs, S. / Hommes, O. R. et al. | 2007
- 67
-
Therapeutic use of dextromethorphan: Key learnings from treatment of pseudobulbar affectMiller, A. / Panitch, H. et al. | 2007
- 74
-
Immunosuppression: Promises and failuresOger, J. l. et al. | 2007
- 79
-
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulatorsYong, V. W. / Zabad, R. K. / Agrawal, S. / Goncalves DaSilva, A. / Metz, L. M. et al. | 2007
- 85
-
Bone marrow transplantation: Does it stop MS progression?Freedman, M. S. et al. | 2007
- 90
-
Relationship of immunologic abnormalities and disease stage in multiple sclerosis: Implications for therapyVaknin-Dembinsky, A. / Weiner, H. L. et al. | 2007
- 95
-
Combination therapy in multiple sclerosisFernández, O. et al. | 2007
- 104
-
Adherence to interferon-beta treatment and results of therapy switchingClerico, M. / Barbero, P. / Contessa, G. / Ferrero, C. / Durelli, L. et al. | 2007
- 109
-
Informed shared decision making in multiple sclerosis—inevitable or impossible?Heesen, C. / Kasper, J. / Köpke, S. / Richter, T. / Segal, J. / Mühlhauser, I. et al. | 2007
- 118
-
Clinical outcome measures in multiple sclerosisAmato, M. P. / Portaccio, E. et al. | 2007
- 123
-
The place of MRI in monitoring the individual MS patientArnold, D. L. et al. | 2007
- 128
-
The gap between effect of drugs and effectiveness of treatmentsSorensen, P. S. et al. | 2007
- 133
-
European Charcot Foundation Symposium “Treatment Strategies in Multiple Sclerosis. From pathophysiology to clinical practice?. 17–19 November 2005:Results from a Round Table Discussion on Rules for individual patient care in MS. J. Palace (chair), M. Amato, G. Comi, G. Edan, M. Friedrichs Bosmans, O.R. Hommes| 2007
- 135
-
Calendar of Events| 2007
- 137
-
Note To Authors| 2007
-
Editorial Board| 2007